CookiesThis site uses cookies to analyze site interaction in order to improve the quality of service and ensure smooth operation of the site. In more detail in Cookies policy
A specialized edition intended for medical institutions and doctors.
logo
Font
Back color
Site version
logo
  • In all sections
  • In medicines
  • In research
  • In news
  • Education hub
Often searched for

Omeprazolе-Darnitsa

Drugs for the treatment of peptic ulcers and gastroesophageal reflux disease. Proton pump inhibitors
Release forms:
Benign gastric and duodenal ulcers, including those specifically associated with the use of nonsteroidal anti-inflammatory drugs; Helicobacter pylori eradication (as part of combination therapy with antibacterial agents); gastroesophageal reflux disease; prevention of aspiration of the acidic stomach contents; Zollinger-Ellison syndrome; relieving the symptoms of acid-dependent dyspepsia.
Characteristics of the productу:
    • Release formCapsule
    • ChildrenAllowed from 5 years
    • PregnantWith caution
    • NursingContraindicated
    • Release categoryPrescription medication
    • DriversWith caution
    • Temperature storage conditionsNot higher than 25 °С
    • Qualitative and quantitative composition:
    • Pharmaceutical form.
    • Pharmacotherapeutic group.
    • Pharmacological properties.
    • Clinical particulars.
    • Therapeutic indications.
    • Contraindications.
    • Interaction with other medicinal products and other forms of interaction
    • Special warnings and precautions for use.
    • Posology and method of administration.
    • Overdose.
    • Undesirable effects.
    • Shelf life.
    • Special precautions for storage.
    • Nature and content of container.
    • Category of release.
    • Manufacturer
    • The manufacturer's location and address of the place of business.
    • Date of last revision.